INTRODUCTION
============

The recent aging of society and, importantly, the spread of antibiotic-resistant strains, makes it worthwhile to consider the different aspects of epididymitis (EP) in older and younger patients, even though the etiology and therapeutic strategies of this disease are considered to be established. Thus, we investigated how age (older or younger) affects EP-related symptoms. EP may have different characteristics in older and younger patients, especially in terms of causative microorganisms and severity; however, research has focused mostly on younger men in the United States \[[@B1]\]. It has been debated whether EP is related to urinary tract infections (UTIs) \[[@B2][@B3][@B4][@B5]\], and the theory suggests that the cause of EP in younger men tends to be sexually transmitted infections (STIs) and that the cause in older men tends to be UTIs. This may be partly because the causative routes of infection are varied, and some routes involve the urinary tract and others involve urogenital organs such as the prostate or seminal vesicle \[[@B6]\].

EP presents with a variety of clinical features or symptoms; for instance, the infection occurrence pattern can be acute or chronic, and the patients may or may not have fever \[[@B5]\]. Differences in the extent of inflammation may help to explain differences in presenting symptoms \[[@B7]\]. Considering that older patients have lower urinary tract symptoms (LUTS) from benign prostatic hyperplasia (BPH) \[[@B8]\], urinary tract factors may affect this infectious disease; for instance, pyuria, bacteriuria, or large volumes of residual urine might be risk factors for EP from UTI.

In this study, we retrospectively examined 308 cases from seven hospitals in Hyogo, Japan, to explore the clinical risk factors for EP-related symptoms, with a particular focus on the patients\' age or urine findings of pyuria or bacteriuria. These findings could provide the basis for prospective or randomized studies to establish the clinical risk factors for EP-related symptoms or algorithms for treatments in the future.

MATERIALS AND METHODS
=====================

1. EP cases
-----------

The EP data were gathered from seven hospitals (Kobe University Hospital, Yodogawa Catholic Hospital, Steel Memorial Hirohata Hospital, Shinko Hospital, Kobe City Medical Center West Hospital, Kobe Red Cross Hospital, and Hara Genitourinary Hospital) in Hyogo, Japan. Data were analyzed retrospectively. This study was admitted by the Kobe University Institutional Review Board and followed the basis of the Declaration of Helsinki (approval number: 160148). EP was diagnosed by the physicians taking care of the patients as induration and tenderness of the epididymis. All patients were diagnosed and treated between April 2007 and July 2012.

2. Data analyses
----------------

All data included the following factors: age, febrile or afebrile, duration to improvement of fever, site, tenderness, pyuria, bacteriuria, and antibiotic treatments. The symptoms investigated were those at the time of diagnosis. In addition, pyuria and bacteriuria were also investigated if they might have caused EP-related symptoms. Pyuria was defined as 5 or more white blood cells per high power field in urine and bacteriuria as a bacterial isolation of 10^5^ or more colony forming units/mL in urine. Bacteriuria was diagnosed by simple urine analysis.

3. Statistical analyses
-----------------------

Statistical analysis was conducted by using chi-square tests with JSTAT (Java Virtual Machine Statistics Monitoring Tool). To examine whether older age (≥65 years) correlated with urine findings or EP-related symptoms in EP patients, we divided the patients into 2 groups by age, 65 years or older and 64 years or younger, and performed statistical analyses on the categories mentioned above. This is because 65 years is regarded as older age in this country. In addition, statistical analyses were conducted to examine whether pyuria or bacteriuria correlated to EP-related symptoms with p\<0.05 considered to indicate statistical significance. These analyses were performed by use of univariate and multivariate analyses, and multiple regression analysis was performed by use of the PASW Statistics 17.0 (SPSS Inc., Chicago, IL, USA).

RESULTS
=======

1. Patient data
---------------

In all cases in which data were available for analysis, age ranged from 5 to 98 years. The site of EP included 150 right cases, 152 left cases, and 4 bilateral cases (2 unknown cases). Sixty-six cases (21.4%) had high fever (≥38℃) and the mean duration to fever suppression was 3.35±1.83 days. Pyuria was seen in 147 of 308 cases (47.7%) and bacteriuria was seen in 152 of 308 cases (49.4%). Causative microorganisms were *Escherichia coli* and *Chlamydia* in 8 cases each (2.6%), respectively. As to other antibiotic-resistant strains, there were 2 cases each of extended spectrum beta-lactamase-producing *E. coli* and methicillin-resistant *Staphylococcus aureus* (0.65%), respectively ([Tables 1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}).

All cases improved after treatment but 2 cases underwent orchiectomy for abscess formation. As therapeutic antibiotics, levofloxacin (133 patients \[43.2%\]), cefozopran (73 patients \[23.7%\]), and ceftriaxone (43 patients \[14.0%\]) were used frequently. One hundred fifty-one patients (49.0%) were treated with 1 kind of antibiotic and 139 (45.1%) were treated with 2 kinds, but mostly they were used as a switching therapy.

2. Comparison data according to age
-----------------------------------

To determine if age correlated with urine findings such as pyuria or bacteriuria or EP-related symptoms such as scrotum swelling or fever, we set 65 years as the cutoff as mentioned above and then compared symptoms between the older age group (≥65 years) and the younger age group (≤64 years). We found that pyuria (p=0.0027) and bacteriuria (p=0.033) were observed at a significantly higher ratio in the older age group than in the younger age group. However, there was no significant correlation between age and duration of fever (p=0.057). In the multivariate analysis, older age groups correlated with pyuria (p=0.0156) ([Table 3](#T3){ref-type="table"}).

3. Comparison data according to presence of pyuria or bacteriuria
-----------------------------------------------------------------

Pyuria was significantly related to fever (p\<0.0001 for 37℃ or higher and p=0.0008 for 38℃ or higher), and this was observed as significant in the multivariate analyses as well (p=0.0159 for 37℃ or higher) ([Table 4](#T4){ref-type="table"}).

DISCUSSION
==========

The notable features of EP are as follows: (1) Identification of the route of infection is sometimes unclear. (2) The causative microorganisms are often undetectable. (3) EP is comparatively easy to diagnose. (4) As mentioned below in the study limitations, it may be hard to test urine or pus cultures because patients with EP, like patients with male urethritis, tend to be cured in clinics and not in research institutions such as a university hospital. Therefore, there are fewer cases with treatment difficulties compared with other urological infections and thus research is lacking. Accordingly, we focused on the correlation between the patient\'s age and urine findings related to inflammation or infection, and EP-related symptoms such as fever in order to further knowledge of EP and its etiology.

Several reports have described the guidelines for the management of EP. Street et al. \[[@B9]\] stated that in their management of epididymo-orchitis they consider mumps and, especially in the immune-compromised host, tuberculosis as possible causative microorganisms and that consideration of gonorrhea is essential for decisions about antibiotics. As to the antibiotic treatments, our cases included a high frequency of fluoroquinolone use according to the literature \[[@B10]\], followed by the third- or fourth-generation cephalosporins. These differences in antibiotic use suggest that (1) our cases included older patients at higher ratios than in other studies and that Enterobacteriaceae, which is not an STI-causing microorganism in general, should have been a target for treatment, and (2) regional guidelines may be necessary because not all regions will have the same trends in patients\' age and causative microorganisms \[[@B11]\].

In terms of causative microorganisms, Bébéar et al. \[[@B12]\] stated in their review that asymptomatic chlamydia infection can cause symptomatic EP and that single-dose antibiotic treatments should be effective in uncomplicated cases. On the other hand, *E. coli* was most often isolated as the causative microorganism in our limited data (because only 41 cases had positive urine or pus culture tests as mentioned below in the study limitations), which differs from other reports in which *Neisseria gonorrhoeae* or *Chlamydia* spp. were the most prevalent \[[@B13][@B14]\]. EP may be caused by symptomatic or asymptomatic UTIs, at least based on our data and especially in the older generation.

A report from Korea showed that epididymo-orchitis was more common in patients not only with a history of urethral stricture but on clean intermittent catheterization (CIC) rather than indwelling urethral catheterization. Those authors also added that CIC, not urethral stricture, is a significant independent risk factor for epididymo-orchitis \[[@B15]\]. Our data showed that pyuria correlated with fever (p=0.0159). In contrast to younger men, in whom sexually transmitted pathogens are predominant, in older patients with a history of subvesical obstruction, *E. coli* is the most frequent pathogen responsible \[[@B16]\]. These data support our data mentioned above and overcome the limited evidence for not only etiology but also treatments, especially in older patients.

We would like to emphasize the limitations of this study. First, the data were retrospectively gathered from seven hospitals over 5 years and lack some elements necessary for definitive statistical analyses. However, we designed the study to include and reflect real clinical EP and its treatments. In particular, bacterial studies were not always available, suggesting that physicians need to be educated on the need for culture tests when treating with antibiotics \[[@B17]\]. Garthwaite et al. \[[@B18]\] discussed the lower implementation rate of the European Urological Association guideline in the management of acute epididymo-architis. However, the references cited in that paper are older and considering the dramatic changes in society, especially in aging and antibiotic-resistant microorganisms, information on this disease needs to be updated by this kind of research. Finally, our data on LUTS were available in only a limited population. These limitations should be overcome by the establishment of therapeutic strategies not only for antibiotic therapies but also for treatment goals and the management of risk factors such as uncontrolled LUTS from BPH including pyuria or bacteriuria.

CONCLUSIONS
===========

Our retrospective data showed that older patients (≥65 years) had a higher ratio of pyuria, and in the multivariate analysis, pyuria may have been significantly correlated with EP-related symptoms (fever) in this study of over 300 cases of EP. These data suggest that age-specific guidelines may be necessary, and for this, additional clinical trials should be considered.
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###### Patients\' characteristics

![](icu-58-205-i001)

  Characteristic                 Value
  ------------------------------ -----------
  No. of cases                   308
  Age (y)                        51.0±20.0
  Body temperature (℃)           
   \<37                          216
   ≥37                           92
  Duration of fever (≥37℃) (d)   3.35±1.83
  Site                           
   Left                          152
   Right                         150
   Bilateral                     4
   Unknown                       2
  Pyuria                         
   (−)                           161
   (+)                           147
  Bacteriuria                    
   (−)                           156
   (+)                           152

Values are presented as number or mean±standard deviation.

###### Causative microorganism and antibiotic treatments
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  Microorganism and antibiotic treatments   Number
  ----------------------------------------- --------
  Causative microorganism                   
   *Escherichia coli*                       8
   *E. coli* (ESBL)                         2
   *Chlamydia*                              8
   MRSA                                     2
   Others                                   5
   Negative                                 9
   Unknown                                  274
  1st line antibiotic treatments            
   Levofloxacin                             133
   Cefozopran                               73
   Ceftriaxone                              43
   Other antibiotics                        57
   Unknown                                  2
  Antibiotics                               
   1 Kind                                   151
   2 Kinds                                  139
   ≥3 Kinds                                 18

ESBL, extended spectrum beta lactamase; MRSA, methicillin-resistant *Staphylococcus aureus*.

###### Comparison between age and epididymitis-related symptoms
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  Variable                       Age (y), n   Univariate   Multivariate                                         
  ------------------------------ ------------ ------------ ------------------- ------------ ------------------- ------------
  Body temperature (℃)                                                                                          
   \<37                          151          65           1.30 (0.78--2.18)   0.388                            
   ≥37                           59           33                                                                
   \<38                          168          74           1.30 (0.73--2.30)   0.456                            
   ≥38                           42           24                                                                
  Duration of fever (≥37℃) (d)   66           28           1.29 (0.99--1.67)   0.057                            
  Swelling                                                                                                      
   (−)                           3            0            1.41 (0.61--3.23)   0.571                            
   (+)                           207          98                                                                
  Pyuria                                                                                                        
   (−)                           122          39           2.09 (1.29--3.42)   0.0027^\*^   1.89 (1.12--3.17)   0.0156^\*^
   (+)                           88           59                                                                
  Bacteriuria                                                                                                   
   (−)                           111          39           1.70 (1.04--2.76)   0.033^\*^    1.38 (0.82--2.32)   0.220
   (+)                           99           59                                                                
  Outcome                                                                                                       
   Conservative                  208          98           2.55 (0.89--4.02)   0.836                            
   Surgical                      2            0                                                                 

OR, odds ratio; CI, confidence interval.

^\*^p\<0.05, statistically significant difference.

###### Comparison between body temperature and urine findings
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  Body temperature (℃)   Pyuria, n   Bacteriuria, n   Univariate   Multivariate                                                          
  ---------------------- ----------- ---------------- ------------ -------------- ------------------- -------------- ------------------- ------------
  \<37                   130         86                                           2.97 (1.78--4.96)   \<0.0001^\*^   2.86 (1.22--6.70)   0.0159^\*^
  ≥37                    31          61                                                                                                  
  \<38                   139         103                                          2.70 (1.52--4.78)   0.0008^\*^     1.06 (0.41--2.76)   0.907
  ≥38                    22          44                                                                                                  
  \<37                                                106          110            1.05 (0.65--1.71)   0.939                              
  ≥37                                                 44           48                                                                    
  \<38                                                120          122            1.18 (0.68--2.04)   0.648                              
  ≥38                                                 30           36                                                                    

OR, odds ratio; CI, confidence interval.

^\*^p\<0.05, statistically significant difference.
